| Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia (NCT02143414) | National Cancer Institute (NCI) | 2015-06-30 |
| Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older (NCT02494882) | Memorial Sloan Kettering Cancer Center | 2015-06-29 |
| Home-exercise Program for Children and Adolescent Survivors of Acute Lymphoblastic Leukemia (NCT03005392) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2015-06-01 |
| Safety and Efficacy of Entospletinib With Vincristine and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) (NCT02404220) | Gilead Sciences | 2015-05-06 |
| A Pilot RCT of the PRISM Intervention for AYAs With Cancer (NCT02340884) | Seattle Children's Hospital | 2015-01-30 |
| Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL) (NCT02185781) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2015-01-28 |
| Treatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia (NCT02336282) | St. Jude Children's Research Hospital | 2015-01-12 |
| Pentoxifylline In Pediatric Acute Lymphoblastic Leukemia During Induction (NCT02451774) | Ramón Óscar González-Ramella, Ph.D | 2015-01-01 |
| Metformin Reduce the Relapse Rate on Patients With B-cell Precursor (Ph+ Negative) Acute Lymphoblastic Leukemia (NCT03118128) | Hospital General de Mexico | 2015-01-01 |
| Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in Children (NCT02339350) | The Korean Society of Pediatric Hematology Oncology | 2015-01-01 |
| Determinants of Mercaptopurine Toxicity in Paediatric Acute Lymphoblastic Leukemia Maintenance Therapy (NCT03920813) | Shandong University | 2015-01-01 |
| Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies (NCT02315612) | National Cancer Institute (NCI) | 2014-12-12 |
| Phase II Front-line Ponatinib in Adult Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia. (NCT01641107) | Incyte Corporation | 2014-12-04 |
| Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults (NCT02228772) | Massachusetts General Hospital | 2014-12-01 |
| Feasibility Neurocognitive Outcome After Transplant (NCT02300961) | Stanford University | 2014-12-01 |
| A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer (NCT02256137) | St. Jude Children's Research Hospital | 2014-10-08 |
| Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections (NCT02231853) | National Heart, Lung, and Blood Institute (NHLBI) | 2014-09-03 |
| A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar) (NCT02257684) | Jazz Pharmaceuticals | 2014-09-01 |
| Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation (NCT02188290) | Kiadis Pharma | 2014-09-01 |
| Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention (NCT01951885) | Case Comprehensive Cancer Center | 2014-07-07 |
| Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients (NCT02042690) | Peking University | 2014-07-01 |
| Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia (NCT02003222) | National Cancer Institute (NCI) | 2014-05-19 |
| Role of the Microparticles and of Tissue Factor in the Pro-thrombotic Phenotype and the Thromboembolic Complications During the Acute Lymphoblastic Leukemia in Children. (NCT02862652) | CHU de Reims | 2014-05-01 |
| Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant (NCT03301168) | Bellicum Pharmaceuticals | 2014-04-01 |
| Red Cell Transfusion Goals in Patients With Acute Leukemias (NCT02086773) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-04-01 |
| Exergaming Intervention in ALL Patients (NCT02118324) | University of Minnesota | 2014-03-01 |
| Targeted Busulfan, Fludarabine, Etoposide Conditioning Regimen for HSCT in Childhood and Adolescent ALL. (NCT02047578) | Seoul National University Hospital | 2014-02-05 |
| Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia (NCT01677949) | Masonic Cancer Center, University of Minnesota | 2013-12-01 |
| AHN-12 Biodistribution in Advanced Leukemia (NCT01207076) | Masonic Cancer Center, University of Minnesota | 2013-12-01 |
| Pegylated Liposomal Doxorubicin Versus Daunorubicin to Treat Acute Lymphoblastic Leukemia: (NCT02070523) | Changzhou Jinyuan Pharmaceutical Manufacturing Co., Ltd. | 2013-12-01 |
| Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination (NCT02007811) | University of Erlangen-Nürnberg Medical School | 2013-11-01 |
| Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic Leukemia (NCT02003612) | Amgen | 2013-10-01 |
| L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) for Treatment of Adult Patients With ALL or LBL (NCT01910428) | ERYtech Pharma | 2013-10-01 |
| Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients (NCT02010931) | Amgen | 2013-09-01 |
| Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma (NCT01943682) | Children's Hospital Medical Center, Cincinnati | 2013-09-01 |
| ATG Could Improve the Outcome Of Hematopoietic Stem Cell Transplant in Patients With Highly Aggressive T Cell Tumors (NCT02290132) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2013-08-01 |
| P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies (NCT01854567) | Mesoblast, Ltd. | 2013-08-01 |
| Study on Two Different Formulations of 6-mercaptopurine. Tablet Versus Oral Liquid (NCT01906671) | Kjeld Schmiegelow | 2013-06-01 |
| Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment (NCT02099266) | University of Kansas Medical Center | 2013-06-01 |
| HD-Idarubicin/Etoposide Intensified Conditioning Regimen Allo-HSCT for Adult ALL (NCT01873807) | Nanfang Hospital, Southern Medical University | 2013-05-01 |
| A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor (NCT01696461) | Center for International Blood and Marrow Transplant Research | 2013-05-01 |
| ALL SCTped FORUM - Pharmacogenomic Study (add-on Study) (NCT02670564) | Swiss Pediatric Oncology Group | 2013-04-01 |
| Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat B-cell Acute Lymphoblastic Leukemia(B-ALL) (NCT01685021) | MorphoSys AG | 2013-04-01 |
| Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia (NCT01842672) | New York Medical College | 2013-03-01 |
| Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor (NCT01794299) | Kiadis Pharma | 2013-03-01 |
| Effect of Bovine Colostrum on Toxicity and Inflammatory Responses (NCT01766804) | Steffen Husby | 2013-03-01 |
| Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant (NCT01744223) | Bellicum Pharmaceuticals | 2013-03-01 |
| Safety and Efficacy Study of Donor Natural Killer Cells Given After Haploidentical Hematopoietic Cell Transplantation (NCT01795378) | Asan Medical Center | 2013-02-01 |
| Busulfan and Cyclophosphamide Followed By ALLO BMT (NCT01685411) | Masonic Cancer Center, University of Minnesota | 2013-01-01 |
| A Dose-finding Study of the Bromodomain (Brd) Inhibitor OTX015/ Birabresib (MK-8628) in Hematologic Malignancies (MK-8628-001) (NCT01713582) | Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2012-12-14 |
| A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy (NCT01643408) | Jazz Pharmaceuticals | 2012-11-01 |
| Clofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) Adults (NCT01462253) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2012-10-01 |
| Bioequivalence of An Oral Mercaptopurine Suspension 100 Mg / 5 Ml Versus Tablet in Healthy Male Subjects Under Fasting Conditions (NCT01697020) | Nova Laboratories Limited | 2012-09-01 |
| A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving (NCT01684150) | Epizyme, Inc. | 2012-09-01 |
| Total Marrow Irradiation for Refractory Acute Leukemia (NCT00686556) | Masonic Cancer Center, University of Minnesota | 2012-08-01 |
| SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (NCT01574274) | Dana-Farber Cancer Institute | 2012-06-01 |
| A Phase I, Dose-finding Study of BEZ235 in Adult Patients With Relapsed or Refractory Acute Leukemia (NCT01756118) | Goethe University | 2012-06-01 |
| Effect of Omega-3 Fatty Acids on Methotrexate Induced Hepatotoxicity in Children With Acute Lymphoblastic Leukemia (NCT02373579) | Nancy Samir Elbarbary | 2012-06-01 |
| CD19-CAR Immunotherapy for Childhood Acute Lymphoblastic Leukemia (ALL) (NCT01195480) | University College, London | 2012-05-01 |
| Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL (NCT03016377) | UNC Lineberger Comprehensive Cancer Center | 2012-03-22 |
| A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives (NCT01532635) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-03-01 |
| Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in Children (NCT01593488) | National Cancer Institute, Naples | 2012-03-01 |
| Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission (NCT01503632) | Children's Oncology Group | 2012-02-21 |
| Therapeutic Interventions For Pain Induced By Vincristine Treatment For Childhood Acute Lymphoblastic Leukemia (ALL) (NCT01506453) | St. Jude Children's Research Hospital | 2012-01-24 |
| Improving Blood Stem Cell Collection and Transplant Procedures (NCT01517035) | National Heart, Lung, and Blood Institute (NHLBI) | 2012-01-13 |
| Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (NCT01471782) | Amgen Research (Munich) GmbH | 2012-01-01 |
| Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT (NCT01810120) | Mariella Enoc | 2012-01-01 |
| Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia (NCT01513603) | New York Medical College | 2012-01-01 |
| Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters Study (NCT01565447) | Oregon Health and Science University | 2011-12-01 |
| A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL (NCT01483690) | Therapeutic Advances in Childhood Leukemia Consortium | 2011-12-01 |
| Metformin and Transient Hyperglycemia (NCT01486043) | Children's Hospital Los Angeles | 2011-12-01 |
| Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) (NCT01466179) | Amgen Research (Munich) GmbH | 2011-12-01 |
| Administration of Donor T Cells With the Caspase-9 Suicide Gene (NCT01494103) | Baylor College of Medicine | 2011-11-01 |
| Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL (NCT01523977) | Dana-Farber Cancer Institute | 2011-11-01 |
| Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia (NCT01424982) | M.D. Anderson Cancer Center | 2011-10-05 |
| Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic Leukemia (NCT01457040) | Nanfang Hospital, Southern Medical University | 2011-10-01 |
| Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) (NCT01324180) | H. Lee Moffitt Cancer Center and Research Institute | 2011-07-18 |
| Combination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (NCT01363128) | M.D. Anderson Cancer Center | 2011-07-12 |
| The Influence of Thiopurine Methyltransferase Activity on Toxicity After High-dose Methotrexate in Childhood Acute Lymphoblastic Leukemia (NCT01886651) | Rigshospitalet, Denmark | 2011-07-01 |
| PEG-Asparaginase Associated Pancreatitis, Hepatotoxicity and Hyperlipidemia in Children With ALL (NCT01393249) | Rigshospitalet, Denmark | 2011-07-01 |
| Comparative Pharmacokinetics of a Compounded 6-mercaptopurine Liquid Formulation Preparation and Tablets (NCT01324336) | Children's Mercy Hospital Kansas City | 2011-07-01 |
| Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (NCT01312818) | Masonic Cancer Center, University of Minnesota | 2011-06-01 |
| Endothelial Function, Arterial Stiffness and Components (NCT01439217) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2011-06-01 |
| Sleep Hygiene and Relaxation Intervention to Improve Sleep and Fatigue for Children Receiving Maintenance Chemotherapy (NCT02295839) | The Hospital for Sick Children | 2011-05-01 |
| Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia (NCT01297543) | Cellerant Therapeutics | 2011-03-01 |
| The Effects of Honey on Febrile Neutropenia in Children With Acute Lymphoblastic Leukemia (NCT02272673) | Ain Shams University | 2011-03-01 |
| WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL) (NCT01266083) | Sellas Life Sciences Group | 2011-01-14 |
| TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation (NCT01300611) | Tarix Pharmaceuticals | 2011-01-01 |
| Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (NCT01256398) | National Cancer Institute (NCI) | 2010-12-14 |
| RFC and MTHFR SNPs & hENT1- dCK Expression as Prognostic Factors in ALL & hENT1- dCK Expression as Prognostic Factors in AML (NCT01307241) | National Institute of Cancerología | 2010-12-01 |
| Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia (NCT01358253) | Ruijin Hospital | 2010-12-01 |
| Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant (NCT01231412) | Fred Hutchinson Cancer Center | 2010-11-01 |
| Utility of XCL1 as a Prognostic Marker in Acute Lymphoblastic Leukemia (NCT01380587) | Hospital Universitario Dr. Jose E. Gonzalez | 2010-11-01 |
| Safety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+ (NCT01354457) | Nantes University Hospital | 2010-11-01 |
| Computerized Intervention for Amelioration of Cognitive Late Effects Among Childhood Cancer Survivors (NCT01217996) | St. Jude Children's Research Hospital | 2010-10-01 |
| PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias (NCT01169012) | UNC Lineberger Comprehensive Cancer Center | 2010-09-01 |
| Effect of Enteral Docosahexaenoic Acid Administration in Children With Acute Lymphoblastic Leukemia (NCT01051154) | Coordinación de Investigación en Salud, Mexico | 2010-09-01 |
| Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies (NCT01188798) | St. Jude Children's Research Hospital | 2010-09-01 |
| Rituximab for Patients With Relapsed Acute Lymphoblastic Leukemia (NCT01230788) | Emory University | 2010-09-01 |
| Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma (NCT01190930) | Children's Oncology Group | 2010-08-11 |